Vulnerability · CVE-2026-0231
An information disclosure vulnerability in Palo Alto Networks Cortex XDR® Broker VM allows an authenticated user to obtain and modify sensitive information by triggeri…
Published Mar 11, 2026 · catalog updated Jun 17, 2026 · the affected product
Last checked Oct 28, 2026. A connected source was read within the last 7 days.
Check if you run it
No confirmed exploitation is on record for CVE-2026-0231. EPSS is 0.17%. Act only if a listed version of the affected product is installed.
Gaps on this record
- No plain product name is stored. The page cannot tell you which product to check.
- No version range is stored. A customer cannot check an installed version against this record.
- No vendor fix or required action is stored. Compare the linked advisory before you change production.
- Severity
- Medium5.7
- Known exploitation
- Not in CISA/VulnCheck KEV
- EPSS
- 0.17%
- Remediation
- Advisory link
- Affected products
- See sources for product scope
An information disclosure vulnerability in Palo Alto Networks Cortex XDR® Broker VM allows an authenticated user to obtain and modify sensitive information by triggering live terminal session via Cortex UI and modifying any configuration setting. The attacker must have network access to the Broker VM to exploit this issue.
No affected version ranges are stored yet. Use the vendor advisory before you decide this record does not apply.
How to fix CVE-2026-0231
No stored fix
No vendor fix text is stored. Use the linked advisory before you change production.
Version check
No version range is stored, so an installed version cannot be checked on this page.
Advisory
Open the cve_org record and follow its fix.
Official advisories
What to do
Three questions, each answered from this record only. Confirm the vendor advisory before you patch.
Should you patch?
No confirmed exploitation is on record for CVE-2026-0231. EPSS is 0.17%. Act only if a listed version of the affected product is installed.
Which versions are affected?
Affected version ranges are not on this record. Compare the installed version with the linked vendor advisory before you change production.
What should an analyst verify?
CWE-497. EPSS 0.17%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.
Code
The project this record applies to. Exploit listings stay in References.
No public source repository is identified for this product.
Timeline
Detection, updates, and resolution for this record.
Mar 11, 2026 · NIST NVD
Detected
An information disclosure vulnerability in Palo Alto Networks Cortex XDR® Broker VM allows an authenticated user to obtain and modify sensitive information by triggering live terminal session via Cortex UI and modifying any configuration setting. The attacker must have network access to the Broker VM to exploit this issue.
Jun 17, 2026 · NIST NVD
Updated
An information disclosure vulnerability in Palo Alto Networks Cortex XDR® Broker VM allows an authenticated user to obtain and modify sensitive information by triggering live terminal session via Cortex UI and modifying any configuration setting. The attacker must have network access to the Broker VM to exploit this issue.
Sources
- CVE.orgVulnerability recordCVE-2026-0231
Official CVE identifier
cve.org - FIRST EPSSExploitation probabilityCVE-2026-0231
30-day exploitation probability 0.17%
first.org - NIST NVDVulnerability recordCVE-2026-0231
An information disclosure vulnerability in Palo Alto Networks Cortex XDR® Broker VM allows an authenticated user to obtain and modify sensitive information by triggering live terminal session via Cortex UI and modifying any configuration setting. The attacker must have network a
nvd.nist.gov
References
Freshness
Last verified in this catalog Oct 28, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.
- FIRST EPSSOct 28, 2026
- CVE.orgOct 16, 2026
- NIST NVDOct 15, 2026